VARIATION IN GUIDELINE-CONCORDANT CONSERVATIVE MANAGEMENT FOR LOW-RISK PROSTATE CANCER

被引：0
|
作者：
Loeb, Stacy
Walter, Dawn
Byrne, Nataliya
Makarov, Danil
机构：
来源：
JOURNAL OF UROLOGY | 2019年 / 201卷 / 04期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP44-10
引用
收藏
页码：E632 / E632
页数：1
相关论文
共 50 条
  • [21] Low-risk Prostate Cancer: Identification, Management, and Outcomes
    Moschini, Marco
    Carroll, Peter R.
    Eggener, Scott E.
    Epstein, Jonathan I.
    Graefen, Markus
    Montironi, Rodolfo
    Parker, Christopher
    [J]. EUROPEAN UROLOGY, 2017, 72 (02) : 238 - 249
  • [22] Variation in the use of active surveillance for low-risk prostate cancer
    Loeppenberg, Bjoern
    Friedlander, David F.
    Krasnova, Anna
    Tam, Andrew
    Leow, Jeffrey J.
    Nguyen, Paul L.
    Barry, Hawa
    Lipsitz, Stuart R.
    Menon, Mani
    Abdollah, Firas
    Sammon, Jesse D.
    Sun, Maxine
    Choueiri, Toni K.
    Kibel, Adam S.
    Quoc-Dien Trinh
    [J]. CANCER, 2018, 124 (01) : 55 - 64
  • [23] Socioeconomic determinants of the receipt of guideline-concordant breast cancer treatment
    McDougali, Jean A.
    Weiss, Noel S.
    Kopecky, Kenneth J.
    Thompson, Beti
    Linden, Hannah M.
    Li, Christopher I.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2014, 23 (11)
  • [24] IMPLEMENTATION OF A PAY-FOR-PERFORMANCE MODEL TO ENHANCE THE UPTAKE OF CONSERVATIVE MANAGEMENT FOR LOW-RISK PROSTATE CANCER
    Gaylis, Franklin
    Dato, Paul
    Catalona, William
    Cooperberg, Matthew
    Prime, Rose
    Cramer, Julie
    Prock, David
    Golshan, Katayune
    Romo, Sonia
    Hu, Steven
    Cohen, Edward
    [J]. JOURNAL OF UROLOGY, 2023, 209 : E57 - E57
  • [25] Temporal trends in the number of men electing for conservative management for low-risk prostate cancer in the United States
    Bashir Al Hussein Al Awamlh
    Karla V. Ballman
    Xiaoyue Ma
    Jim C. Hu
    Jonathan E. Shoag
    [J]. Prostate Cancer and Prostatic Diseases, 2020, 23 : 714 - 717
  • [26] Temporal trends in the number of men electing for conservative management for low-risk prostate cancer in the United States
    Al Hussein Al Awamlh, Bashir
    Ballman, Karla V.
    Ma, Xiaoyue
    Hu, Jim C.
    Shoag, Jonathan E.
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2020, 23 (04) : 714 - 717
  • [27] Low-risk prostate cancer
    Stief, C. G.
    Roosen, A.
    [J]. UROLOGE, 2014, 53 (07): : 1030 - 1030
  • [28] Clinical and Demographic Factors Associated With Receipt of Non Guideline-concordant Initial Therapy for Nonmetastatic Prostate Cancer
    Hamilton, Ann S.
    Fleming, Steven T.
    Wang, Dian
    Goodman, Michael
    Wu, Xiao-Cheng
    Owen, Jean B.
    Lo, Mary
    Ho, Alex
    Anderson, Roger T.
    Thompson, Trevor
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2016, 39 (01): : 55 - 63
  • [29] Physician Variation in Management of Low-Risk Prostate Cancer A Population-Based Cohort Study
    Hoffman, Karen E.
    Niu, Jiangong
    Shen, Yu
    Jiang, Jing
    Davis, John W.
    Kim, Jeri
    Kuban, Deborah A.
    Perkins, George H.
    Shah, Jay B.
    Smith, Grace L.
    Volk, Robert J.
    Buchholz, Thomas A.
    Giordano, Sharon H.
    Smith, Benjamin D.
    [J]. JAMA INTERNAL MEDICINE, 2014, 174 (09) : 1450 - 1459
  • [30] Time Trends and Variation in the Use of Active Surveillance for Management of Low-risk Prostate Cancer in the US
    Cooperberg, Matthew R.
    Meeks, William
    Fang, Raymond
    Gaylis, Franklin D.
    Catalona, William J.
    Makarov, Danil V.
    [J]. JAMA NETWORK OPEN, 2023, 6 (03) : E231439
12345